Edwards Lifesciences Corp Stock Widgets and Gadgets
| EW Stock | USD 86.45 0.79 0.91% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- EW Edwards Lifesciences Corp
- Latest Disposition of 6320 shares by Daniel Lippis of Edwards Lifesciences at 88.78 subject to Rule 16b-3
- EW 86.45 -0.79
- Low 85.98
- High 87.35
- Volume 3.1 M
- Alpha 0.2
- Beta 0.76
- Return On Equity 0.22
- Return On Asset 0.12
- Profit Margin 0.23 %
- Operating Margin 0.39 %
- Current Valuation 51.1 B
- Shares Outstanding 601.93 M
- Shares Owned By Insiders 0.88 %
- Shares Owned By Institutions 84.00 %
- Number Of Shares Shorted 10.38 M
- Price To Earning 32.77 X
- Price To Book 8.17 X
- Price To Sales 9.05 X
- Revenue 6 B
- Gross Profit 4.3 B
- EBITDA 1.53 B
- Net Income 1.4 B
- Cash And Equivalents 769 M
- Cash Per Share 2.81 X
- Total Debt 694.9 M
- Debt To Equity 0.11 %
- Current Ratio 3.83 X
- Book Value Per Share 11.06 X
- Cash Flow From Operations 895.8 M
- Short Ratio 2.57 X
- Earnings Per Share 2.30 X
- Price To Earnings To Growth 5.19 X
- Target Price 94.28
- Number Of Employees 19.8 K
- Beta 1.07
- Market Capitalization 52.04 B
- Total Asset 9.36 B
- Retained Earnings 8.99 B
- Working Capital 2.84 B
- Current Asset 2.05 B
- Current Liabilities 476.2 M
- Net Asset 9.36 B
- Accumulation Distribution 48966.12
- Daily Balance Of Power (0.58)
- Rate Of Daily Change 0.99
- Day Median Price 86.67
- Day Typical Price 86.59
- Price Action Indicator (0.61)
- Period Momentum Indicator (0.79)
Market Snapshot Widget Example
DAX Index Germany | 17,837 0.38 | |
Taiwan Weighted Taiwan | 20,301 0.43 | |
PSI 20 Stock Portugal | 6,328 1.50 | |
CROBEX Croatia | 2,803 0.35 | |
Budapest SE Hungary | 65,674 0.67 | |
IDX 30 Jakarta Indonesia | 474.44 0.75 | |
ISEQ 20 Price Ireland | 1,628 0.48 | |
NYSE Comp USA | 17,388 0.09 | |
Tel Aviv 35 Israel | 1,912 1.29 | |
Coreshares Index Tracker South Afric | 1,030 0.88 | |
IPC MEXICO Mexico | 55,739 0.11 | |
KL Technology Malaysia | 63.89 0.14 | |
IBEX 35 Index Spain | 10,765 1.23 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,538 0.87 | |
SPASX Dividend Opportunities Australia | 1,661 0.59 | |
HNX 30 Vietnam | 484.87 2.28 | |
Bucharest BET-NG Romania | 1,207 0.53 | |
AMS Small Cap Netherlands | 1,208 0.74 | |
Oslo Exchange Mutual Norway | 1,291 0.38 | |
BEL Small Belgium | 8,962 0.02 | |
RTSI Index Russia | 1,160 0.54 | |
Basic Materials Brazil | 5,868 0.0041 | |
Swiss Leader Price Switzerland | 1,837 0.12 | |
Fondo Mutuo ETF Chile | 1,428 0.94 | |
Athens General Comp Greece | 1,381 1.14 | |
Stock Exchange Of Thailand | 1,361 0.43 | |
PX Prague Stock Czech Repub | 1,548 0.04 | |
THE PHILIPPINE STOCK Philippines | 6,523 1.13 | |
WIG 30 Poland | 3,051 1.24 | |
BIST Electricity Turkey | 583.83 0.78 |
Investing Ideas
In addition to having Edwards Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Edwards Lifesciences
Compare Edwards Lifesciences To Peers
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.